Citation Impact
Citing Papers
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2
2011 Standout
Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Metagenomic Analysis of the Human Distal Gut Microbiome
2006 StandoutScience
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Altered fecal microbiota composition in patients with major depressive disorder
2015 Standout
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
2013 Standout
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients
1996
The Role of Short-Chain Fatty Acids in Health and Disease
2014 Standout
Review article: the role of butyrate on colonic function
2007 Standout
Predictors of Persistence of Use of the Novel Antidiabetic Agent Acarbose
2001
Glycosylation inhibitors in biology and medicine
1995
Effects of acarbose on fecal nutrients, colonic pH, and short-chain fatty acids and rectal proliferative indices
1996
Dietary Polyphenols and the Prevention of Diseases
2005 Standout
α‐Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects
1994
The metabolic syndrome
2010 Standout
The abundance and variety of carbohydrate-active enzymes in the human gut microbiota
2013 Standout
Microbiota and SCFA in Lean and Overweight Healthy Subjects
2009 Standout
Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transporter translocation
1996
Oral Antihyperglycemic Therapy for Type 2 Diabetes
2002
Effects of resistant starch on the colon in healthy volunteers: possible implications for cancer prevention
1998
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
2016 Standout
Digestion and physiological properties of resistant starch in the human large bowel
1996
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Sulfonylurea Pharmacotherapy Regimen Adherence in a Medicaid Population: Influence of Age, Gender, and Race
1999
The metabolic syndrome
2005 Standout
Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus<SUBTITLE>Progressive Requirement for Multiple Therapies (UKPDS 49)</SUBTITLE>
1999 Standout
Effect of Short‐Chain Fatty Acids on the Human Colonic Mucosa in Vitro
1992
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
2013 Standout
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
Type 2 diabetes
2017 Standout
Medicinal plants of India with anti-diabetic potential
2002 Standout
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
1995 Standout
Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy
2003
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Regulation of intestinal epithelial permeability by tight junctions
2012 Standout
Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation
1994
Effect of inhibition of α-glucosidase on age-related glucose intolerance and pancreatic atrophy in rats
2006
Role of the gut microbiota in nutrition and health
2018 Standout
Current Therapeutic Options in Type 2 Diabetes Mellitus: A Practical Approach
2003
Colonic Health: Fermentation and Short Chain Fatty Acids
2006 Standout
Gut flora in health and disease
2003 Standout
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
2010
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
The Physiology of Glucagon-like Peptide 1
2007 Standout
Fecal Short-Chain Fatty Acids in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: In Vitro Studies of Carbohydrate Fermentation
1996
Glucagon-like Peptide 1 (7-36 hide) Secretion in Response to Luminal Sucrose from the Upper and Lower Gut: A Study Using α-Glucosidase Inhibition (Acarbose)
1995
Short-chain fatty acids in control of body weight and insulin sensitivity
2015 Standout
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
Effect of isomalt consumption on faecal microflora and colonic metabolism in healthy volunteers
2006
Type 2 diabetes mellitus
2015 Standout
Antidiabetic plants and their active constituents
1995
Effect of Energy‐Reduced Diets High in Dairy Products and Fiber on Weight Loss in Obese Adults
2005
The possible role of postprandial hyperglycaemia in the pathogenesis of diabetic complications
2003
Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: A meta-analysis
2007
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
2006 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides
2001 Standout
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
2007 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States
2006 Standout
Different Polyphenolic Components of Soft Fruits Inhibit α-Amylase and α-Glucosidase
2005 Standout
Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids
2016 Standout
Spermidine in health and disease
2018 StandoutScience
A Systematic Review of Adherence With Medications for Diabetes
2004 Standout
Investigating Cellular Metabolism of Synthetic Azidosugars with the Staudinger Ligation
2002 StandoutNobel
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Acarbose: oral antidiabetes drug with additional cardiovascular benefits
2008
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
2000
Alpha-glucosidase inhibitors for type 2 diabetes mellitus
2005
Fructans of Jerusalem artichokes: intestinal transport, absorption, fermentation, and influence on blood glucose, insulin, and C-peptide responses in healthy subjects
1990
Cardiovascular safety of sulfonylureas: a meta‐analysis of randomized clinical trials
2013
Works of M. Spengler being referenced
Acarbose treatment does not change the habitual diet of patients with Type 2 diabetes mellitus
2000
European study on dose-response relationship of acarbose as a first-line drug in non-insulin-dependent diabetes mellitus: efficacy and safety of low and high doses
1998
Effect of Starch Malabsorption on Colonic Function and Metabolism in Humans
1988
Efficacy of 24-Week Monotherapy With Acarbose, Metformin, or Placebo in Dietary-Treated NIDDM Patients
1997
Palatinit bei Typ-II-Diabetikern: Wirkung auf Blutglucose, Seruminsulin, C-Peptid und freie Fettsäuren im Vergleich mit Glucose
2008
Comparative study of isomalt and sucrose by means of continuous indirect calorimetry
1984
Beneficial effects on serum lipids in noninsulin dependent diabetics by acarbose treatment.
1991
Efficacy of 6 months monotherapy with glucosidase inhibitor Acarbose versus sulphonylurea glibenclamide on metabolic control of dietary treated type II diabetics (NIDDM).
1992
Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet Alone
1991
Efficacy of 24-Week Monotnerapy With Acarbose, Glibenclamide, or Placebo in NIDDM Patients: The Essen Study
1994